Non-squamous Non-small-cell Lung Cancer research hub

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

This study looks at a drug called crizotinib for advanced lung cancer where specific gene changes (ROS1 or MET) are found. It aims to see how well the drug works in these patients.